GROSSMAN ADAM S (President and CEO) received a stock award from ADMA BIOLOGICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/11/2026ACC: 0001140361-26-004890
DirectorOfficer· President and CEO
Since Feb 2026
+727.24K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
727.24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+282.53K
Price / share
—
Trade value
—
% of position
14.1%
2/9/2026
2.01M→2.29M
Total
Net shares
+282.53K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/9/2026 | A · Award | +282.53K | — | — | 14.1% | 2.01M | 2.29M |
| Total | +282.53K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
444.71K shares
Shares
+444.71K
Strike price
16.37
Held after
444.71K
Exercisable
—
2/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock444.71K shares | 2/9/2026 | A · Award | +444.71K | 16.37 | — | 444.71K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned580.96K
Common Stock
IndirectShares owned1.14M
Total
1.72M indirect1.72M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 580.96K | Indirect |
| Common Stock | 1.14M | Indirect |
| Total | 1.72M | 1.72M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported